Acute and persistent infection of human neural cell lines by human coronavirus OC43

Journal of Virology

Volumn 73, Issue 4, 1999, Pages 3338-3350

  Arbour, Nathalie ^a   Côté, Geneviève ^a   Lachance, Claude ^a   Tardieu, Marc ^b   Cashman, Neil R ^c   Talbot, Pierre J ^a  

^a INRS INSTITUT ARMAND FRAPPIER   (Canada)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MONOCLONAL ANTIBODY; VIRUS ANTIGEN;

ANTIGEN DETECTION; ARTICLE; ASTROCYTE; ASTROCYTOMA CELL; CELL LINE; CONTROLLED STUDY; CORONAVIRUS; HUMAN; HUMAN CELL; INFECTION SENSITIVITY; MICROGLIA; NERVE CELL; NEUROTROPISM; NONHUMAN; NUCLEOTIDE SEQUENCE; OLIGODENDROGLIA; PERSISTENT INFECTION; POINT MUTATION; PRIORITY JOURNAL; VIRION; VIRUS GENOME; VIRUS INFECTION; VIRUS PARTICLE;

EID: 0344859876     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.4.3338-3350.1999     Document Type: Article

References (86)

1. Adami, C., J. Pooley, J. Glomb, E. Stecker, F. Fazal, J. O. Fleming, and S. C. Baker. 1995. Evolution of mouse hepatitis virus (MHV) during chronic infection: quasispecies nature of the persisting MHV RNA. Virology 209: 337-346.
2. Ahmed, R., C. S. Hahn, T. Somasundaram, L. Villarete, M. Matloubian, and J. H. Strauss. 1991. Molecular basis of organ-specific selection of viral variants during chronic infection. J. Virol. 65:4242-4247.
3. Aksamit, A. R., Jr. 1995. Progressive multifocal eukoencephalopathy: a review of the pathology and pathogenesis. Microsc. Res. Tech. 32:302-311.
4. Arbour, N., S. Ekandé, G. Côté, C. Lachance, F. Chagnon, M. Tardieu, N. R. Cashman, and P. J. Talbot. 1999. Persistent infection of human oligodendrocytic and neuroglial cell lines by human coronavirus 229E. J. Virol. 73: 3326-3337.
5. Arbour, N., and P. J. Talbot. 1998. Persistent infection of neural cell lines by human coronaviruses. Adv. Exp. Med. Biol. 440:575-581.
6. Arbour, N., and P. J. Talbot. Unpublished data.
7. Barnett, E. M., and S. Perlman. 1993. The olfactory nerve and not the trigeminal nerve is the major site of CNS entry for mouse hepatitis virus, strain JHM. Virology 194:185-191.
8. Barthold, S. W., M. S. de Souza, and A. L. Smith. 1990. Susceptibility of laboratory mice to intranasal and contact infection with coronaviruses of other species. Lab. Anim. Sci. 40:481-185.
9. Barthold, S. W., and A. L. Smith. 1992. Viremic dissemination of mouse hepatitis virus-JHM following intranasal inoculation of mice. Arch. Virol. 122:35-44.
10. b-restricted cytotoxic T cell response. J. Gen. Virol. 77:315-325.
11. Bocchini, V., R. Casalone, P. Collini, G. Rebel, and F. Lo Curto. 1991. Changes in glial fibrillary acidic protein and karyotype during culturing of two cell lines established from human glioblastoma multiforme. Cell Tissue Res. 265:73-81.
12. Bonavia, A., N. Arbour, V. W. Yong, and P. J. Talbot. 1997. Infection of primary cultures of human neural cells by human coronaviruses 229E and OC43. J. Virol. 71:800-806.
13. Buchmeier, M. J., R. G. Dalziel, M. J. M. Koolen, and P. W. Lampert. 1987. Molecular determinants of CNS virulence of the coronavirus mouse hepatitis virus-4, p. 409-422. In M. A. Brinton and R. R. Rueckert (ed.), Positive-strand RNA viruses. Alan R. Liss, Inc., New York, N.Y.
14. Cabirac, G. F., K. F. Soike, J.-Y. Zhang, K. Hoel, C. Butunoi, G.-Y. Cai, S. Johnson, and R. S. Murray. 1994. Entry of coronavirus into primate CNS following peripheral infection. Microb. Pathog. 16:349-357.
15. + T-cell epitopes within the surface glycoprotein of a ncurotropic coronavirus and correlation with pathogenicity. J. Virol. 69:8127-8131.
16. Chen, W., and R. S. Baric. 1996. Molecular anatomy of mouse hepatitis virus persistence: coevolution of increased host cell resistance and virus virulence. J. Virol. 70:3947-3960.
17. Chen, W., and R. S. Baric. 1995. Function of a 5′-end genomic RNA mutation that evolves during persistent mouse hepatitis virus infection in vitro. J. Virol. 69:7529-7540.
18. Collins, A. R. 1998. Human macrophages are susceptible to coronavirus OC43. Adv. Exp. Med. Biol. 440:635-639.
19. Collins, A. R., R. L. Knobler, H. Powell, and M. J. Buchmeier. 1982. Monoclonal antibodies to murine hepatitis virus-4 (strain JHM) define the viral glycoprotein responsible for attachment and cell-cell fusion. Virology 119: 358-371.
20. Collins, A. R., and O. Sorensen. 1986. Regulation of viral persistence in human glioblastoma and rhabdosarcoma cells infected with coronavirus OC43. Microb. Pathog. 1:573-582.
21. Daniel, C., R. Anderson, M. J. Buchmeier, J. O. Fleming, W. J. M. Spaan, H. Wege, and P. J. Talbot. 1993. Identification of an immunodominant linear neutralization domain of the S2 portion of the murine coronavirus spike glycoprotein and evidence that it forms part of a complex tridimensional structure. J. Virol. 67:1185-1194.
22. Dveksler, G. S., M. N. Pensiero, C. B. Cardellichio, R. K. Williams, G. S. Jiang, K. V. Holmes, and C. W. Dieffenbach. 1991. Cloning of the mouse hepatitis virus (MHV) receptor: expression in human and hamster cell lines confers susceptibility to MHV. J. Virol. 65:6881-6891.
23. Ercolani, L., B. Florence, M. Denaro, and M. Alexander. 1988. Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene. J. Biol. Chem. 263:15335-15341.
24. Fazakerley, J. K., S. E. Parker, F. Bloom, and M. J. Buchmeier. 1992. The V5A13.1 envelope glycoprotein deletion mutant of mouse hepatitis virus type-4 is neuroattenuated by its reduced rate of spread in the central nervous system. Virology 187:178-188.
25. Fazzini, E., J. Fleming, and S. Fahn. 1992. Cerebrospinal fluid antibodies to coronavirus in patients with Parkinson's disease. Mov. Disord. 7:153-158.
26. Fleming, J. O., J. J. Houtman, H. Alaca, H. C. Hinze, D. McKenzie, J. Aiken, T. Bleasdale, and S. Baker. 1994. Persistence of viral RNA in the central nervous system of mice inoculated with MHV-4. Adv. Exp. Med. Biol. 342: 327-332.
27. Fleming, J. O., M. D. Trousdale, J. Bradbury, S. A. Stohlman, and L. P. Weiner. 1987. Experimental demyelination induced by coronavirus JHM (MHV-4): molecular identification of a viral determinant of paralytic disease. Microb. Pathog. 3:9-20.
28. Flintoff, W. F., and S. Van Dinter. 1989. Several rat cell lines share a common defect in their inability to internalize murine coronaviruses efficiently. J. Gen. Virol. 70:1713-1724.
29. Gallagher, T. M., S. E. Parker, and M. J. Buchmeier. 1990. Neutralization-resistant variants of a neurotropic coronavirus are generated by deletions within the amino-terminal half of the spike glycoprotein. J. Virol. 64:731-741.
30. Gombold, J. L., S. T. Hingley, and S. R. Weiss. 1993. Fusion-defective mutants of mouse hepatitis virus A59 contain a mutation in the spike protein cleavage signal. J. Virol. 67:4504-4512.
31. Gonzalez-Dunia, D., C. Sauder, and J. C. de la Torre. 1997. Borna disease virus and the brain. Brain Res. Bull. 44:647-664.
32. Hamre, D., and J. J. Procknow. 1966. A new virus isolated from the human respiratory tract. Proc. Soc. Exp. Biol. Med. 121:190-193.
33. Houtman, J. J., and J. O. Fleming. 1996. Pathogenesis of mouse hepatitis virus-induced demyclination. J Neurovirol. 2:361-376.
34. Janabi, N., S. Peudenier, B. Héron, K. H. Ng, and M. Tardieu. 1995. Establishment of human microglial cell lines after transfection of primary cultures of embryonic microglia cells with the SV40 large T antigen. Neurosci. Lett. 195:105-108.
35. Kamahora, T., L. H. Soe, and M. M. C. Lai. 1989. Sequence analysis of nucleocapsid gene and leader RNA of human coronavirus OC43. Virus Res. 12:1-9.
36. Klenerman, P., Hengartner, and R. M. Zinkernagel. 1997. A non-retroviral RNA virus persists in DNA form. Nature 390:298-301.
37. Knobler, R. L., P. W. Lampert, and M. B. A. Oldstone. 1982. Virus persistence and recurring demyelination produced by a temperature-sensitive mutant of MHV-4. Nature 298:279-280.
38. Komurasaki, Y., C. N. Nagineni, Y. Wang, and J. J. Hooks. 1996. Virus RNA persists within the retina in coronavirus-induced retinopathy. Virology 222: 446-450.
39. Künkel, F., and G. Herrler. 1996. Structural and functional analysis of the S proteins of two human coronavirus OC43 strains adapted to grow in different cells. Arch. Virol. 141:1123-1131.
40. Künkel, F., and G. Herrler. 1993. Structural and functional analysis of the surface protein of human coronavirus OC43. Virology 195:195-202.
41. Lai, M. M. C., and D. Cavanagh. 1997. The molecular biology of coronaviruses. Adv. Virus Res. 48:1-100.
42. Lavi, E., P. S. Fishman, P. S. Highkin, and S. R. Weiss. 1988. Limbic encephalitis after inhalation of a murine coronavirus. Lab. Investig. 58:31-36.
43. Lavi, E., D. H. Gilden, M. K. Highkin, and S. R. Weiss. 1984. Persistence of mouse hepatitis virus A59 RNA in a slow virus demyelinating infection in mice as detected by in situ hybridization. J. Virol. 51:563-566.
44. Levine, B., and D. E. Griffin. 1992. Persistence of viral RNA in mouse brains after recovery from acute alphavirus encephalitis. J. Virol. 66:6429-6435.
45. Liebert, U. G. 1997. Measles virus infections of the central nervous system. Intervirology 40:176-184.
46. Lucas, A., M. Coulter, R. Anderson, S. Dales, and W. Flintoff. 1978. In vivo and in vitro models of demyelinating diseases. II. Persistence and host-regulated thermosensitivity in cells of neural derivation infected with mouse hepatitis and measles viruses. Virology 88:325-337.
47. Makino, S., J. O. Fleming, J. G. Keck, S. A. Stohlman, and M. M. C. Lai. 1987. RNA recombination of coronaviruses: localization of neutralizing epitopes and neuropathogenic determinants on the carboxyl terminus of peplomers. Proc. Natl. Acad. Sci. USA 84:6567-6571.
48. Massa, P. T., H. Wege, and V. ter Meulen. 1988. Growth pattern of various JHM coronavirus isolates in primary rat glial cell cultures correlates with differing neurotropism in vivo. Virus Res. 9:133-144.
49. McIntosh, K., W. B. Becker, and R. M. Chanock. 1967. Growth in suckling-mouse brain of "IBV-like" viruses from patients with upper respiratory tract disease. Proc. Natl. Acad. Sci. USA 58:2268-2273.
50. McIntosh, K., J. McQuillin, S. E. Reed, and P. S. Gardner. 1978. Diagnosis of human coronavirus infection by immunofluorescence: method and application to respiratory disease in hospitalized children. J. Med. Virol. 2:341-346.
51. McLaurin, J., G. C. Trudel, I. T. Shaw, J. P. Antel, and N. R. Cashman. 1995. A human glial hybrid cell line differentially expressing genes subserving oligodendrocyte and astrocyte phenotype. J. Neurobiol. 26:283-293.
52. Morris, V. L., C. Tieszer, J. Mackinnon, and D. Percy. 1989. Characterization of coronavirus JHM variants isolated from Wistar Furth rats with a viral-induced demyelinating disease. Virology 169:127-136.
53. Mounir, S., and P. J. Talbot. 1993. Molecular characterization of the S protein gene of human coronavirus OC43. J. Gen. Virol. 74:1981-1987.
54. Mounir, S., and P. J. Talbot. 1992. Sequence analysis of the membrane protein gene of human coronavirus OC43 and evidence for O-glycosylation. J. Gen. Virol. 73:2731-2736.
55. Murray, R. S., B. Brown, D. Brian, and G. F. Cabirac. 1992. Detection of coronavirus RNA and antigen in multiple sclerosis brain. Ann. Neurol. 31:525-533.
56. Murray, R. S., G. Y. Cai, K. Hoel, J.-Y. Zhang, K. F. Soike, and G. F. Cabirac. 1992. Coronavirus infects and causes demyelination in primate central nervous system. Virology 188:274-284.
57. Murray, R. S., G. Y. Cai, K. F. Soike, and G. F. Cabirac. 1997. Further observations on coronavirus infection of primate CNS. J. Neurovirol. 3:71-75.
58. Myint, S. H. 1994. Human coronaviruses - a brief review. Rev. Med. Virol. 4:35-46.
59. Okumura, A., K. Machii, S. Azuma, Y. Toyoda, and S. Kyuwa. 1996. Maintenance of pluripotency in mouse embryonic stem cells persistently infected with murine coronavirus. J. Virol. 70:4146-4149.
60. Pearson, J., and C. A. Mims. 1985. Differential susceptibility of cultured neural cells to the human coronavirus OC43. J. Virol. 53:1016-1019.
61. Perlman, S., G. Evans, and A. Afifi. 1990. Effect of olfactory bulb ablation on spread of a neurotropic coronavirus into the mouse brain. J. Exp. Med. 172: 1127-1132.
62. Perlman, S., G. Jacobsen, and A. Afifi. 1989. Spread of a neurotropic murine coronavirus into the CNS via the trigeminal and olfactory nerves. Virology 170:556-560.
63. Perlman, S., and D. Ries. 1987. The astrocyte is a target cell in mice persistently infected with mouse hepatitis virus, strain JHM. Microb. Pathog. 3: 309-314.
64. Resta, S., J. P. Luby, C. R. Rosenfeld, and J. D. Siegel. 1985. Isolation and propagation of a human enteric coronavirus. Science 229:978-981.
65. Riski, H., and T. Hovi. 1980. Coronavirus infections of man associated with diseases other than the common cold. J. Med. Virol. 6:259-265.
66. Rowe, C. L., S. C. Baker, M. J. Nathan, and J. O. Fleming. 1997. Evolution of mouse hepatitis virus: detection and characterization of spike deletion variants during persistent infection. J. Virol. 71:2959-2969.
67. Salmi, A., B. Ziola, T. Hovi, and M. Reunanen. 1982. Antibodies to coronaviruses OC43 and 229E in multiple sclerosis patients. Neurology 32:292-295.
68. Sizun, J., N. Arbour, and P. J. Talbot 1998. Comparison of immunofluorescence with monoclonal antibodies and RT-PCR for the detection of human coronaviruses 229E and OC43 in cell culture. J. Virol. Methods 72:145-152.
69. Smith, D. B., J. McAllister, C. Casino, and P. Simmonds. 1997. Virus 'quasispecies': making a mountain out of a molehill? J. Gen. Virol. 78:1511-1519.
70. Sorensen, O., M. B. Coulter-Mackie, S. Puchalski, and S. Dales. 1984. In vivo and in vitro models of demyelinating disease. IX. Progression of JHM virus infection in the central nervous system of the rat during overt and asymptomatic phases. Virology 137:347-357.
71. Sorensen, O., and S. Dales. 1985. In vivo and in vitro models of demyelinating disease: JHM virus in the rat central nervous system localized by in situ cDNA hybridization and immunofluorescent microscopy. J. Virol. 56: 434-438.
72. Sorensen, O., R. Dugre, D. Percy, and S. Dales. 1982. In vivo and in vitro models of demyelinating disease: endogenous factors influencing demyelinating disease caused by mouse hepatitis virus in rats and mice. Infect. Immun. 37:1248-1260.
73. Stewart, J. N., S. Mounir, and P. J. Talbot. 1992. Human coronavirus gene expression in the brains of multiple sclerosis patients. Virology 191:502-505.
74. Stohlman, S. A., and L. P. Weiner. 1978. Stability of neurotropic mouse hepatitis virus (JHM strain) during chronic infection of neuroblastoma cells. Arch. Virol. 57:53-61.
75. Stühler, A., E. Flory, H. Wege, H. Lassmann, and H. Wege. 1997. No evidence for quasispecies populations during persistence of the coronavirus mouse hepatitis virus JHM: sequence conservation within the surface glycoprotein S in Lewis rats. J. Gen. Virol. 78:747-756.
76. Sun, N., D. Grzybicki, R. F. Castro, S. Murphy, and S. Perlman. 1995. Activation of astrocytes in the spinal cord of mice chronically infected with a neurotropic coronavirus. Virology 213:482-493.
77. Sun, N., and S. Perlman. 1995. Spread of a neurotropic coronavirus to spinal cord white matter via neurons and astrocytes. J. Virol. 69:633-641.
78. Taguchi, F., P. T. Massa, and V. ter Meulen. 1986. Characterization of a variant virus isolated from neural cell culture after infection of mouse coronavirus JHMV. Virology 155:267-270.
79. Taguchi, F., S. G. Siddell, H. Wege, and V. ter Meulen. 1985. Characterization of a variant virus selected in rat brains after infection by coronavirus mouse hepatitis virus JHM. J. Virol 54:429-435.
80. Takahashi, K., N. Goto, T. Ishida, K. Katami, and K. Fujiwara. 1981. Acute demyelination in mice inoculated intraspinally with mouse hepatitis virus, JHM strain. Jpn. J. Exp. Med. 51:323-330.
81. Talbot, P. J., A. A. Salmi, R. L. Knobler, and M. J. Buchmeier. 1984. Topographical mapping of epitopes on the glycoproteins of murine hepatitis virus-4 (strain JHM): correlation with biological activities. Virology 131:250-260.
82. Tardieu, M., O. Boespflug, and T. Barbé. 1986. Selective tropism of a neurotropic coronavirus for ependymal cells, neurons, and meningeal cells. J. Virol. 60:574-582.
83. Watanabe, R., H. Wege, and V. Ter Meulen. 1983. Adoptive transfer of EAE-like lesions from rats with coronavirus-induced demyelinating encephalomyelitis. Nature 305:150-153.
84. Wege, H. 1995. Immunopathological aspects of coronavirus infections. Springer Semin. Immunopathol. 17:133-148.
85. Wege, H., J. Winter, and R. Meyermaan. 1988. The peplomer protein E2 of coronavirus JHM as a determinant of neurovirulence: definition of critical epitopes by variant analysis. J. Gen. Virol. 69:87-98.
86. Yokomori, K., and M. M. C. Lai. 1992. Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. J. Virol. 66:6194-6199.